Price to Earnings (P/E)
since 2013
Calculation
IQVIA Holdings Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income attributable to IQVIA Holdings Inc.1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | 38.65 | = | 227.03 | ÷ | 5.87 | 5.87 | = | 1,091 | ÷ | 185,722,621 | |
| Feb 16, 2022 | 45.78 | = | 232.18 | ÷ | 5.07 | 5.07 | = | 966 | ÷ | 190,485,264 | |
| Feb 12, 2021 | 132.09 | = | 192.66 | ÷ | 1.46 | 1.46 | = | 279 | ÷ | 191,281,286 | |
| Feb 18, 2020 | 166.58 | = | 165.42 | ÷ | 0.99 | 0.99 | = | 191 | ÷ | 192,339,093 | |
| Feb 19, 2019 | 107.95 | = | 141.49 | ÷ | 1.31 | 1.31 | = | 259 | ÷ | 197,599,861 | |
| Feb 16, 2018 | 16.18 | = | 101.72 | ÷ | 6.29 | 6.29 | = | 1,309 | ÷ | 208,251,468 | |
| Feb 16, 2017 | 157.56 | = | 76.87 | ÷ | 0.49 | 0.49 | = | 115 | ÷ | 235,719,111 | |
| Feb 11, 2016 | 18.19 | = | 59.00 | ÷ | 3.24 | 3.24 | = | 387 | ÷ | 119,384,993 | |
| Feb 12, 2015 | 22.06 | = | 63.25 | ÷ | 2.87 | 2.87 | = | 356 | ÷ | 124,315,113 | |
| Feb 13, 2014 | 29.91 | = | 52.20 | ÷ | 1.75 | 1.75 | = | 227 | ÷ | 129,842,707 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of IQVIA Holdings Inc. Annual Report.
Comparison to Competitors
IQVIA Holdings Inc., P/E, long-term trends, comparison to competitors
| IQVIA Holdings Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | 38.65 | 22.62 | 19.56 | 23.97 | 25.65 | 50.08 | 22.68 | 22.97 | 19.21 | 7.58 | 19.68 | 30.55 |
| Feb 16, 2022 | 45.78 | 22.07 | 21.05 | 20.92 | 29.94 | 40.66 | 12.36 | 20.93 | 14.78 | 11.76 | 8.37 | 27.35 |
| Feb 12, 2021 | 132.09 | 40.17 | 18.82 | — | 44.49 | 31.95 | 641.48 | 28.92 | 26.72 | 19.62 | 15.09 | 27.89 |
| Feb 18, 2020 | 166.58 | 17.82 | 17.07 | 41.99 | 38.34 | 16.19 | 16.45 | 25.99 | 20.60 | 11.63 | 19.86 | 33.36 |
| Feb 19, 2019 | 107.95 | 20.60 | 14.01 | 16.81 | 29.77 | 39.13 | 15.26 | 23.74 | 33.46 | 21.58 | 18.17 | 35.19 |
| Feb 16, 2018 | 16.18 | 35.47 | 64.06 | 103.55 | 27.25 | — | 22.75 | 268.10 | 61.63 | 9.99 | 28.99 | 37.66 |
| Feb 16, 2017 | 157.56 | 16.54 | 16.03 | 20.56 | 23.02 | 32.39 | 6.83 | 20.08 | 46.14 | 28.10 | 42.64 | 30.45 |
| Feb 11, 2016 | 18.19 | 17.01 | 15.95 | 64.22 | 17.85 | 33.35 | 6.75 | 18.80 | 31.64 | 26.37 | 60.50 | 26.19 |
| Feb 12, 2015 | 22.06 | 55.08 | 22.96 | 49.80 | 23.69 | 33.06 | 12.85 | 17.15 | 13.94 | 23.03 | 118.44 | 27.26 |
| Feb 13, 2014 | 29.91 | 19.64 | 18.69 | 35.01 | 19.74 | 13.88 | 42.00 | 18.72 | 37.83 | 9.32 | 77.00 | 38.43 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
IQVIA Holdings Inc., P/E, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| IQVIA Holdings Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 15, 2023 | 38.65 | 20.15 |
| Feb 16, 2022 | 45.78 | 19.12 |
| Feb 12, 2021 | 132.09 | 35.63 |
| Feb 18, 2020 | 166.58 | 20.58 |
| Feb 19, 2019 | 107.95 | 22.89 |
| Feb 16, 2018 | 16.18 | 34.49 |
| Feb 16, 2017 | 157.56 | 20.28 |
| Feb 11, 2016 | 18.19 | 18.89 |
| Feb 12, 2015 | 22.06 | 20.74 |
| Feb 13, 2014 | 29.91 | 19.10 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
Comparison to Industry (Health Care)
IQVIA Holdings Inc., P/E, long-term trends, comparison to industry (health care)
| IQVIA Holdings Inc. | Health Care | |
|---|---|---|
| Feb 15, 2023 | 38.65 | 330,078.16 |
| Feb 16, 2022 | 45.78 | 20.96 |
| Feb 12, 2021 | 132.09 | 28.69 |
| Feb 18, 2020 | 166.58 | 20.94 |
| Feb 19, 2019 | 107.95 | 25.33 |
| Feb 16, 2018 | 16.18 | 29.68 |
| Feb 16, 2017 | 157.56 | 21.38 |
| Feb 11, 2016 | 18.19 | 19.10 |
| Feb 12, 2015 | 22.06 | 20.89 |
| Feb 13, 2014 | 29.91 | 18.14 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).